Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Many skin patients have mental health issues, so dermatologists should consider psychological care.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Early balding at 40 increases prostate cancer risk.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Finasteride does not prevent bladder cancer.

Some skin diseases and their treatments can negatively affect male fertility.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.